These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16690475)

  • 1. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
    Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
    Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid acropachy.
    McCarthy J; Twersky J; Lion M
    J Can Assoc Radiol; 1975 Sep; 26(3):199-202. PubMed ID: 1242722
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid acropachy: an unusual rheumatic manifestation of Graves' disease.
    Capsoni F; Minonzio F; Sarzi-Puttini P; Atzeni F; Ambrosi B
    Clin Exp Rheumatol; 2005; 23(1):125-6. PubMed ID: 15789906
    [No Abstract]   [Full Text] [Related]  

  • 4. [A rare hyperthyroid syndrome].
    Artuso V; Roiter I
    Minerva Endocrinol; 2004 Jun; 29(2):71-5. PubMed ID: 15257258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy.
    Ogrin C
    Thyroid; 2008 Nov; 18(11):1227-9. PubMed ID: 19014329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual vignette. Diagnosis: thyroid acropachy, the rare musculoskeletal manifestation of Graves' hyperthyroidism.
    Iqbal N; Diamond JM
    Endocr Pract; 2006; 12(2):234. PubMed ID: 16690475
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
    Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
    Bunevicius R; Prange AJ
    CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).
    Bartalena L; Chiovato L; Vitti P
    J Endocrinol Invest; 2016 Oct; 39(10):1105-14. PubMed ID: 27319009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
    Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
    J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotoxicosis.
    Kannan CR; Seshadri KG
    Dis Mon; 1997 Sep; 43(9):601-77. PubMed ID: 9301645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' hyperthyroidism in pregnancy.
    Nguyen CT; Mestman JH
    Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):232-240. PubMed ID: 31389810
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.